Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines

The role of CDK4/6 inhibitors in the treatment of metastatic breast cancer

A multidisciplinary team approach to cancer care in the Philippines

Amivantamab shows robust efficacy in post-platinum therapy patients with EGFR Ex20ins NSCLC

Four chemo cycles given with durvalumab and tremelimumab optimise response and tumour shrinkage in patients with mNSCLC

CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC

Latest treatments in oesophageal cancer

Final data from phase II study of eftilagimod alpha and pembro in PD-1/PD-L1 inhibitors resistant second line metastatic NSCLC

The importance of training to improve cancer care in the Philippines

Radiotherapy for multiple cancer types in the Philippines

Complementary and alternative medicine for cancer in the Philippines

The Choosing Wisely Philippines project and its impact